Vietnam Opens Modern Bio-Safety Lab To Detect Bird Flu, SARS Viruses
This article was originally published in PharmAsia News
Vietnam opened an $8 million level 3 bio-safety laboratory to test viral infections for the H5N1 bird flu strain and for severe acute respiratory syndrome. The lab is to be managed by the National Institute of Hygiene and Epidemiology to offer a method of quickly detecting and responding to outbreaks for those diseases and other dangerous viruses. In the past, the country had to send specimens to other countries for testing. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.